Listing analysis and research matching collaboration:
Pension funds highlight the importance of collaboration to pharmaceutical companies
A report, sponsored by three pension investment funds the USS, ABP Investment and OPERS, who between them have US $20 billion invested in healthcare, has been released offering one view on the future research and development structure of the pharmaceutical industry.
GE Healthcare alliances in the medical devices and diagnostic market
GE Healthcare, a $17 billion unit of General Electric Company, has an active alliance programme in a range of technologies covering medical imaging, healthcare IT, diagnostic imaging agents, patient monitoring, drug discovery and protein separation.
Procter and Gamble relies on collaboration to drive innovation
At the start of 2000 Procter and Gamble's newly appointed chief executive officer, AG Lafley, announced that the company would move away from a model based on in-house innovation towards sourcing more of its innovation from outside. Mr Lafley's stated goal was that P&G would become known as the company that 'collaborates, inside and out, better than any other company in the world'. His target was to source 50% of the company's innovation from external companies. At the time only 15% of P&G's innovation came from outside.
Big hopes from small technologies
Promising smaller, lighter, quicker and better-performing materials, components and systems, nanotechnology could open new opportunities for collaborations in a number of sectors ranging from pharmaceuticals to medical devices, chemicals, energy and technology. That's what the proponents of the technology argue, anyway.
Takeda flexes it's partnering muscles
Are the Japanese healthcare majors emerging as serious competitors to the largest North American and European pharmaceutical companies for the most partners for fast growing biotechnology companies? Japan's largest pharmaceutical company, Takeda Pharmaceutical, the sixteenth largest pharmaceutical company in the world, certainly believes so.
GE and Lilly ink cancer diagnostics linkup
In a sign of the accelerating convergence between treatments and diagnostics GE and Eli Lilly have announced a collaboration to develop in vitro diagnostic assays that may help predict cancer treatment response to targeted therapies.
Pfizer invests in web-based software company
Why is Pfizer so heavily behind a struggling web-based software company operating in a crowded space?
Alliances drive the hunt for clean energy
Motor companies looking to perfect hybrid and plug-in electric cars as the solution to soaring oil costs and concerns about the environment see alliances as the way forward.
Getting to the bottom of alliance failure rates
Nearly fifty percent of alliances 'fail'. Right? Well no actually.
